DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Drug Eluting Balloons (DEBs) Market 2017-2021" report to their offering.
The global drug eluting balloons market to grow at a CAGR of 27.14% during the period 2017-2021.
The report, Global Drug Eluting Balloons Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is favorable reimbursement policies. Advanced and innovative devices such as DEBs are more expensive than BMS and plain balloon catheters. End-users such as hospitals and ASCs will be reluctant to stock DEBs if reimbursement is not available.
According to the report, one driver in the market is growing demand for cath labs. Cath labs in hospitals conduct both diagnostic and therapeutic procedures. As a part of treatment for coronary heart diseases, physicians perform coronary angiography and PCI for diagnosis. These procedures help confirm the severity of the disease, allowing physicians to determine treatment plans. To examine the coronary anatomy and to determine a disease, physicians use cardiac catheterization.
Key vendors
- B. Braun Melsungen
- Cook Medical
- C.R. Bard
- Eurocor
- Medtronic
Other prominent vendors
- Aachen Resonance
- Acrostak
- Cardionovum
- Spectranetics
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end-user
PART 08: Geographical segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
For more information about this report visit https://www.researchandmarkets.com/research/hbnkzh/global_drug
